Apotex, Pfizer Make Peace On Generic Neurontin
Apotex Corp. and Pfizer Inc. have settled all outstanding patent infringement and antitrust litigation over Pfizer's blockbuster epilepsy drug, Neurontin, which had earned the company more than $2 billion a year....To view the full article, register now.
Already a subscriber? Click here to view full article